IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Achilles Therapeutics PL (698)

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Trium Capital LLP
INCREASED
Shares61,506 from 30,753
Change+30,753 (+100%)
Value$91.0K (+$45.5K)
Filed 2026-07-16
Rhumbline Advisers
UNCHANGED
Shares4,480 from 4,480
Change0 (0%)
Value$6.6K ($0)
Filed 2026-08-12
Gamma Investing LLC
UNCHANGED
Shares806 from 806
Change0 (0%)
Value$1.2K ($0)
Filed 2026-07-07
Status
Trium Capital LLP
INCREASED61,50630,753+30,753+100%$45.5K$91.0K+$45.5K2026-07-16
Rhumbline Advisers
UNCHANGED4,4804,48000%$6.6K$6.6K$02026-08-12
Gamma Investing LLC
UNCHANGED80680600%$1.2K$1.2K$02026-07-07
Showing 3 of 3 institutions